Cambodia vaccinating ages 3-4 to fight omicron outbreak
Cambodia is vaccinating 3- and 4-year-olds with Chinese-made Sinovac shots after finding young children accounting for many new infections
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Cambodia began vaccinating 3- and 4-year-olds with Chinese-made Sinovac shots Wednesday after finding young children accounting for many new infections.
Prime Minister Hun Sen appealed for parents to get their children vaccinated as soon as they can and said five of his 21 grandchildren and one of his daughters have tested positive for the omicron variant of the coronavirus.
“To overcome COVID-19 depends not just on the government or the Health Ministry, but needs the participation of all the people,” Hun Sen said at a groundbreaking ceremony for a wastewater treatment facility on the outskirts of the capital Phnom Penh.
He had endorsed the vaccination plan for the younger children last week after health officials found at least 25% of newly reported infections involved children under 5.
After vaccinating adults and older children, Cambodia approved shots for ages 6-11 in September last year as part of reopening its schools. In November, vaccinations for 5-year-olds were approved.
More than 80% of Cambodia’s almost 17 million people have received at least two shots. China’s Sinovac and Sinopharm vaccines account for most inoculations.
A recent sharp rise in the number of cases had driven some residents in Phnom Penh to stock antiviral medication to treat their illness or prepare for the possibility of catching the virus.
They have been purchasing Molnupiravir — a pill developed by the pharmaceutical company Merck — which was authorized by the Health Ministry last November for home-based treatment of mild to moderate cases. Cambodia has purchased 4 million pills, suitable for treating 10,000 people.
Cambodia’s Health Ministry on Wednesday reported 558 new COVID-19 cases and one related death, bringing the nation’s totals since the pandemic began to 128,133 cases and 3,023 deaths.